Clinical Trial Update: NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating NS1209 with lidocaine for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Lidocaine (Lidocaine)
• NS1209

Snippet

Sponsor: Danish Pain Research Center | Conditions: Pain | Phase 2 | Status: COMPLETED